Receiving a diagnosis of squamous cell carcinoma (SCC) can be an overwhelming experience, but it is important to remember ...

Personal cancer journey emphasizes the emotional and physical challenges faced by patients during diagnosis and treatment. Patient advocacy is crucial in navigating the healthcare system and making ...

Tailoring treatment to patient risk and disease burden is crucial, especially for those with extensive actinic keratosis or recurrent keratinocyte cancers. Speakers delved into innovative strategies ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved cemiplimab-rwlc for adjuvant treatment of adults with cutaneous squamous cell carcinoma at ...

Zynyz is marketed by Incyte in the U.S. In 2017, Incyte entered into an exclusive collaboration and license agreement with MacroGenics, Inc. for global rights to retifanlimab. Zynyz is a registered ...

Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–Associated Oropharyngeal Cancer: Swallowing Outcomes From ECOG-ACRIN E3311 Impaired homologous ...

Immunotherapy combined with hypofractionated radiotherapy and chemotherapy for locally recurrent rectal cancer (TORCH-R): A prospective, single-arm, two-cohort, phase II trial. This is an ASCO Meeting ...

A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according ...